Suchergebnisse - "Jurinovic, Vindi"

PubPharm (6)

1

Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma : A Prospective Analysis of the Phase III GALLIUM Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Pott, C. | Jurinovic, V. | Trotman, J. | +19

2

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

enthalten in: Blood advances | 2020

von Alig, S. | Jurinovic, V. | Shahrokh Esfahani, M. | +23

3

Impact of age on clinical risk scores in follicular lymphoma

enthalten in: Blood advances | 2019

von Alig, S. | Jurinovic, V. | Pastore, A. | +8

4

Impact of age on genetics and treatment efficacy in follicular lymphoma

enthalten in: Haematologica | 2018

von Alig, S. | Jurinovic, V. | Pastore, A. | +13

5

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy

enthalten in: Blood | 2018

von Mottok, A. | Jurinovic, V. | Farinha, P. | +14

6

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma : a retrospective analysis of a prospective clinical trial and validation in a population-based registry

enthalten in: The Lancet. Oncology | 2015

von Pastore, A. | Jurinovic, V. | Kridel, R. | +32

CommentIn: Lancet Oncol. 2015 Sep;16(9):1011-2. - PMID 26256759

1
[1]